XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Impact of adoption
Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Impact of adoption
Treasury Stock
Retained Earnings
Retained Earnings
Impact of adoption
Beginning balance at Dec. 31, 2020 $ 10,691                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Accretion adjustments of redeemable noncontrolling interest to redemption value 473                
Net income / (loss) attributable to common stockholders (280)                
Ending balance at Mar. 31, 2021 10,884                
Balance (in shares) at Dec. 31, 2020     0 49,631,000     147,000    
Balance at Dec. 31, 2020 467,752   $ 0 $ 496 $ 405,831   $ (5,149) $ 66,574  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued in connection with equity-based plans (in shares)       173,000          
Common stock issued in connection with equity-based plans 1,989     $ 2 1,987        
Stock-based compensation expense 7,888       7,888        
Equity component of convertible senior notes, net 56,515       56,515        
Accretion adjustments of redeemable noncontrolling interest to redemption value (473)       (473)        
Net income / (loss) attributable to common stockholders 14,830             14,830  
Balance (in shares) at Mar. 31, 2021     0 49,804,000     147,000    
Balance at Mar. 31, 2021 548,501   $ 0 $ 498 471,748   $ (5,149) 81,404  
Beginning balance at Dec. 31, 2020 10,691                
Ending balance at Jun. 30, 2021 11,372                
Balance (in shares) at Dec. 31, 2020     0 49,631,000     147,000    
Balance at Dec. 31, 2020 $ 467,752   $ 0 $ 496 405,831   $ (5,149) 66,574  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchases of treasury stock (in shares) 0                
Balance (in shares) at Jun. 30, 2021     0 50,041,000     147,000    
Balance at Jun. 30, 2021 $ 573,437   $ 0 $ 500 481,937   $ (5,149) 96,149  
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                
Beginning balance at Dec. 31, 2020 $ 10,691                
Ending balance at Dec. 31, 2021 12,888                
Balance (in shares) at Dec. 31, 2020     0 49,631,000     147,000    
Balance at Dec. 31, 2020 467,752   $ 0 $ 496 405,831   $ (5,149) 66,574  
Balance (in shares) at Dec. 31, 2021     0 50,407,000     147,000    
Balance at Dec. 31, 2021 613,167 $ (46,543) $ 0 $ 504 498,979 $ (56,515) $ (5,149) 118,833 $ 9,972
Beginning balance at Mar. 31, 2021 10,884                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Accretion adjustments of redeemable noncontrolling interest to redemption value 743                
Net income / (loss) attributable to common stockholders (255)                
Ending balance at Jun. 30, 2021 11,372                
Balance (in shares) at Mar. 31, 2021     0 49,804,000     147,000    
Balance at Mar. 31, 2021 548,501   $ 0 $ 498 471,748   $ (5,149) 81,404  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued in connection with equity-based plans (in shares)       237,000          
Common stock issued in connection with equity-based plans $ 878     $ 2 876        
Purchases of treasury stock (in shares) 0                
Stock-based compensation expense $ 10,056       10,056        
Accretion adjustments of redeemable noncontrolling interest to redemption value (743)       (743)        
Net income / (loss) attributable to common stockholders 14,745             14,745  
Balance (in shares) at Jun. 30, 2021     0 50,041,000     147,000    
Balance at Jun. 30, 2021 573,437   $ 0 $ 500 481,937   $ (5,149) 96,149  
Beginning balance at Dec. 31, 2021 12,888                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Accretion adjustments of redeemable noncontrolling interest to redemption value 2,569                
Net income / (loss) attributable to common stockholders (176)                
Ending balance at Mar. 31, 2022 15,281                
Balance (in shares) at Dec. 31, 2021     0 50,407,000     147,000    
Balance at Dec. 31, 2021 613,167 (46,543) $ 0 $ 504 498,979 (56,515) $ (5,149) 118,833 9,972
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued in connection with equity-based plans (in shares)       85,000          
Common stock issued in connection with equity-based plans 1,080     $ 1 1,079        
Purchases of treasury stock (in shares)             354,000    
Purchase of treasury stock (23,331)           $ (23,331)    
Stock-based compensation expense 12,110       12,110        
Accretion adjustments of redeemable noncontrolling interest to redemption value (2,569)       (2,569)        
Net income / (loss) attributable to common stockholders 9,079             9,079  
Balance (in shares) at Mar. 31, 2022     0 50,492,000     501,000    
Balance at Mar. 31, 2022 $ 562,993   $ 0 $ 505 453,084   $ (28,480) 137,884  
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                
Beginning balance at Dec. 31, 2021 $ 12,888                
Ending balance at Jun. 30, 2022 16,127                
Balance (in shares) at Dec. 31, 2021     0 50,407,000     147,000    
Balance at Dec. 31, 2021 $ 613,167 $ (46,543) $ 0 $ 504 498,979 $ (56,515) $ (5,149) 118,833 $ 9,972
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchases of treasury stock (in shares) 834,654                
Purchase of treasury stock $ (51,500)                
Balance (in shares) at Jun. 30, 2022     0 50,697,000     982,000    
Balance at Jun. 30, 2022 561,283   $ 0 $ 507 468,698   $ (56,648) 148,726  
Beginning balance at Mar. 31, 2022 15,281                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Accretion adjustments of redeemable noncontrolling interest to redemption value 860                
Net income / (loss) attributable to common stockholders (14)                
Ending balance at Jun. 30, 2022 16,127                
Balance (in shares) at Mar. 31, 2022     0 50,492,000     501,000    
Balance at Mar. 31, 2022 562,993   $ 0 $ 505 453,084   $ (28,480) 137,884  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued in connection with equity-based plans (in shares)       205,000          
Common stock issued in connection with equity-based plans $ 583     $ 2 581        
Purchases of treasury stock (in shares) 480,531           481,000    
Purchase of treasury stock $ (28,168)           $ (28,168)    
Reclassification of subsidiary long-term incentive plan liability related to modification 3,104       3,104        
Stock-based compensation expense 12,789       12,789        
Accretion adjustments of redeemable noncontrolling interest to redemption value (860)       (860)        
Net income / (loss) attributable to common stockholders 10,842             10,842  
Balance (in shares) at Jun. 30, 2022     0 50,697,000     982,000    
Balance at Jun. 30, 2022 $ 561,283   $ 0 $ 507 $ 468,698   $ (56,648) $ 148,726